Broad Institute Of Mit And Harvard

This early-stage trial tests a new drug called PrP-siRNA in 30 adults with symptomatic prion disease, a rare and fatal brain condition. The drug is given via a spinal injection and aims to reduce levels of the harmful prion protein. The main goal is to check safety, but researche…